Literature DB >> 8886989

Transport of protein kinase C alpha into the nucleus requires intact cytoskeleton while the transport of a protein containing a canonical nuclear localization signal does not.

D Schmalz1, F Kalkbrenner, F Hucho, K Buchner.   

Abstract

Protein kinase C undergoes a redistribution from the cytosol into the nucleus upon various stimuli. Since protein kinase C does not contain any known nuclear localization signal, the exact pathway and mechanism of the translocation into the nucleus is not known. We used immunofluorescence microscopy to investigate the role of the cytoskeleton in this process, and to detect the subcellular distribution of protein kinase C alpha in NIH 3T3 fibroblasts. In these cells protein kinase C alpha is translocated into the nucleus after stimulation with phorbol ester. We observed that cells treated with the cytoskeleton disrupting agents cytochalasin B or colchicine do not show the nuclear translocation of protein kinase C alpha after stimulation. In contrast, the nuclear accumulation of a nuclear localization signal containing reporter protein in an in vitro nuclear transport assay is not affected by these drugs. This observation has been confirmed for intact cells by microinjection experiments: cells which have been incubated with cytochalasin B or colchicine prior to microinjection of the reporter protein show the same accumulation in the nucleus as untreated cells. Our data show that intact cytoskeleton plays an important role in the translocation of protein kinase C alpha into the nucleus but not in the nuclear import of a karyophilic reporter protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886989     DOI: 10.1242/jcs.109.9.2401

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

1.  Nuclear localization signal receptor importin alpha associates with the cytoskeleton.

Authors:  H M Smith; N V Raikhel
Journal:  Plant Cell       Date:  1998-11       Impact factor: 11.277

Review 2.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

3.  A single point mutation in the V3 region affects protein kinase Calpha targeting and accumulation at cell-cell contacts.

Authors:  A Vallentin; T C Lo; D Joubert
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells.

Authors:  P Antony; J N Kanfer; L Freysz
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

Review 5.  Protein kinase C in the immune system: from signalling to chromatin regulation.

Authors:  Pek Siew Lim; Christopher Ray Sutton; Sudha Rao
Journal:  Immunology       Date:  2015-10-06       Impact factor: 7.397

Review 6.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

Review 7.  Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function.

Authors:  Viktoria Kheifets; Daria Mochly-Rosen
Journal:  Pharmacol Res       Date:  2007-05-03       Impact factor: 7.658

8.  Functional actin cytoskeleton is required in early stage of NETosis induction.

Authors:  Ming-Lin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-15       Impact factor: 11.205

Review 9.  Recent progress in the mechanistic understanding of NET formation in neutrophils.

Authors:  Ming-Lin Liu; Xing Lyu; Victoria P Werth
Journal:  FEBS J       Date:  2021-06-11       Impact factor: 5.622

10.  A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression.

Authors:  Alessandro Poli; Giulia Ramazzotti; Alessandro Matteucci; Lucia Manzoli; Annalisa Lonetti; Pann-Ghill Suh; James A McCubrey; Lucio Cocco
Journal:  Oncotarget       Date:  2014-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.